What Part of the Wellness Economy Should Be Pursued by Health Systems?
I came across an article inForbes discussing beauty and wellness trends for 2020 (see:9 Beauty And Wellness Trend Predictions For 2020 And Beyond). Included in the article was the graphic shown below that categorizes the global wellness economy for 2017 into various segments. All of this raised the question in my mind about how health systems can pursue a portion of this huge wellness market without straying too far from their roots. First, take a look at the graph below.I believe that it would be relatively easy for health systems to become more engaged in three segments of the global wellness industry as shown above. They are: (1)traditional and complementary medicine (2)preventive and personalized medicine, and (3)nutrition and weight loss. Many health systems have already embraced complementary and alternative medicine (CAM) with enthusiasm in (see:Complementary and Alternative Medicine in the United States.). Similarly, most health systems have also developed nutritional and weight loss programs. Many physicians tend to be the most enthusiastic about bariatric surgery because the results can be dramatic. Some diseases like Type 2 diabetes can also be ameliorated by bariatric surgery (see:How Weight Loss Surgery Helps Type 2 Diabetes).In my mind, however, the segment of wellness that is, and will continue to. be most important for health systems is preventive and personalized medicine. To be very specific, such engagement by hospitals will involve embracing and ...
HbA1c values also declined across a sample of program participants, many of whom said they were unfamiliar with the diabetes management tools prior to enrollment.
CONCLUSION: All these results indicate that SQC is an effective preventive and protective drug on skeletal muscle of diabetic macrovasculopathy, and could alleviate skeletal muscle tissue damage through affecting biological functions related to cell death and cell adhesion. PMID: 32096754 [PubMed - as supplied by publisher]
Condition: Diabetes Mellitus, Type 2 Intervention: Device: iRF System Hepatic Denervation Sponsor: Metavention Not yet recruiting
Condition: Diabetes Mellitus, Type 2 Interventions: Dietary Supplement: Vitamin K; Other: Placebo Sponsor: Cairo University Recruiting
Condition: Type 2 Diabetes Mellitus Intervention: Drug: Trelagliptin Sponsor: Takeda Not yet recruiting
Changes in labeling, formularies, and drug formulations were among the factors contributing to shifts in type 2 diabetes drug prescribing practices in the US.Medscape Medical News
Abstract The sum of squared score (SSU) and sequence kernel association test (SKAT) are the two good alternative tests for genetic association studies in case-control data. Both SSU and SKAT are derived through assuming a dose-response model between the risk of disease and genotypes. However, in practice, the real genetic mode of inheritance is impossible to know. Thus, these two tests might losepower substantially as shown in simulation results when the genetic model is misspecified. Here, to make both the tests suitable in broad situations, we propose two-phase SSU (tpSSU) and two-phase SKAT (tpSKAT), where the ...
CONCLUSIONS: The mechanism underlying this phenomenon relates to a decrease in the inflammatory reaction and oxidative stress, as well as a decrease in leaky gut. Such reactions increase insulin sensitivity and reduce autoimmune responses. PMID: 32096204 [PubMed - in process]